Healthcare provider profile · identity verified

Duane D Strand, MD

Internal Medicine · WAHPETON, ND · NPI 1871521245

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	683	146
Amlodipine Besylate	Amlodipine Besylate	644	155
Metoprolol Succinate	Metoprolol Succinate	642	125
Rosuvastatin Calcium	Rosuvastatin Calcium	505	118
Gabapentin	Gabapentin	448	94
Lisinopril	Lisinopril	425	98
Tamsulosin Hcl	Tamsulosin Hcl	395	81
Metformin Hcl	Metformin Hcl	390	72
Levothyroxine Sodium	Levothyroxine Sodium	365	69
Furosemide	Furosemide	342	70
Omeprazole	Omeprazole	304	62
Simvastatin	Simvastatin	283	60
Eliquis	Apixaban	273	29
Jardiance	Empagliflozin	263	28
Losartan Potassium	Losartan Potassium	261	61
Metformin Hcl Er	Metformin Hcl	226	46
Mirtazapine	Mirtazapine	222	40
Pantoprazole Sodium	Pantoprazole Sodium	220	43
Donepezil Hcl	Donepezil Hcl	202	40
Escitalopram Oxalate	Escitalopram Oxalate	195	35
Allopurinol	Allopurinol	186	38
Famotidine	Famotidine	182	33
Buspirone Hcl	Buspirone Hcl	170	19
Sertraline Hcl	Sertraline Hcl	168	26
Carvedilol	Carvedilol	156	31
Hydrochlorothiazide	Hydrochlorothiazide	151	41
Trazodone Hcl	Trazodone Hcl	151	19
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	150	25
Ozempic	Semaglutide	137	19
Citalopram Hbr	Citalopram Hydrobromide	133	23
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	131	30
Pravastatin Sodium	Pravastatin Sodium	130	21
Metoprolol Tartrate	Metoprolol Tartrate	129	35
Warfarin Sodium	Warfarin Sodium	123	14
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	113	17
Ezetimibe	Ezetimibe	99	27
Isosorbide Mononitrate Er	Isosorbide Mononitrate	99	21
Finasteride	Finasteride	97	22
Albuterol Sulfate Hfa	Albuterol Sulfate	96	26
Montelukast Sodium	Montelukast Sodium	94	17
Januvia	Sitagliptin Phosphate	93	13
Quetiapine Fumarate	Quetiapine Fumarate	91	suppressed
Spironolactone	Spironolactone	91	11
Potassium Chloride	Potassium Chloride	89	27
Jantoven	Warfarin Sodium	83	25
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	83	15
Glipizide	Glipizide	76	16
Bupropion Xl	Bupropion Hcl	73	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	72	suppressed
Clopidogrel	Clopidogrel Bisulfate	71	19
Farxiga	Dapagliflozin Propanediol	71	13
Duloxetine Hcl	Duloxetine Hcl	70	15
Trulicity	Dulaglutide	63	suppressed
Alendronate Sodium	Alendronate Sodium	62	19
Memantine Hcl	Memantine Hcl	60	suppressed
Glipizide Er	Glipizide	59	13
Prednisone	Prednisone	58	15
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	54	13
Carbidopa-Levodopa	Carbidopa/Levodopa	50	suppressed
Fluticasone Propionate	Fluticasone Propionate	50	16
Tresiba Flextouch U-100	Insulin Degludec	46	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	45	suppressed
Cephalexin	Cephalexin	44	23
Hydroxyzine Pamoate	Hydroxyzine Pamoate	44	suppressed
Hydralazine Hcl	Hydralazine Hcl	43	11
Tramadol Hcl	Tramadol Hcl	41	suppressed
Dutasteride	Dutasteride	39	suppressed
Bumetanide	Bumetanide	38	suppressed
Pregabalin	Pregabalin	38	suppressed
Novolog Flexpen	Insulin Aspart	36	suppressed
Xarelto	Rivaroxaban	36	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	35	12
Klor-Con M10	Potassium Chloride	35	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	35	23
Humalog Mix 75-25 Kwikpen	Insulin Lispro Protamin/Lispro	34	suppressed
Klor-Con M20	Potassium Chloride	34	suppressed
Atenolol	Atenolol	33	suppressed
Baclofen	Baclofen	33	suppressed
Synthroid	Levothyroxine Sodium	32	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	31	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	31	suppressed
Gemfibrozil	Gemfibrozil	30	suppressed
Methimazole	Methimazole	30	suppressed
Benztropine Mesylate	Benztropine Mesylate	29	suppressed
Benazepril Hcl	Benazepril Hcl	28	suppressed
Digoxin	Digoxin	28	suppressed
Divalproex Sodium	Divalproex Sodium	28	suppressed
Lovastatin	Lovastatin	28	suppressed
Lamotrigine	Lamotrigine	27	suppressed
Trintellix	Vortioxetine Hydrobromide	27	suppressed
Paroxetine Hcl	Paroxetine Hcl	26	suppressed
Ropinirole Er	Ropinirole Hcl	26	suppressed
Chlorthalidone	Chlorthalidone	25	suppressed
Fenofibrate	Fenofibrate,micronized	25	suppressed
Humalog Kwikpen U-100	Insulin Lispro	25	suppressed
Meloxicam	Meloxicam	25	suppressed
Midodrine Hcl	Midodrine Hcl	25	suppressed
Rybelsus	Semaglutide	25	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	24	14
Nitroglycerin	Nitroglycerin	24	21
Ropinirole Hcl	Ropinirole Hcl	24	suppressed
Latanoprost	Latanoprost	23	suppressed
Olanzapine	Olanzapine	23	suppressed
Glimepiride	Glimepiride	22	suppressed
Nebivolol Hcl	Nebivolol Hcl	21	suppressed
Rivastigmine	Rivastigmine	21	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	20	suppressed
Celecoxib	Celecoxib	20	suppressed
Nystatin	Nystatin	19	14
Levetiracetam	Levetiracetam	18	suppressed
Oxycodone Hcl	Oxycodone Hcl	18	suppressed
Topiramate	Topiramate	18	suppressed
Tresiba Flextouch U-200	Insulin Degludec	18	suppressed
Diclofenac Sodium	Diclofenac Sodium	17	11
Doxazosin Mesylate	Doxazosin Mesylate	17	suppressed
Myrbetriq	Mirabegron	17	suppressed
Alprazolam	Alprazolam	16	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	16	13
Fiasp Flextouch	Insulin Aspart (Niacinamide)	16	suppressed
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	16	suppressed
Levemir Flexpen	Insulin Detemir	15	suppressed
Nystop	Nystatin	15	suppressed
Ondansetron Hcl	Ondansetron Hcl	15	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	15	suppressed
Ursodiol	Ursodiol	15	suppressed
Azelastine Hcl	Azelastine Hcl	14	suppressed
Humalog Mix 75-25	Insulin Lispro Protamin/Lispro	14	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	14	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	14	suppressed
Ulticare Pen Needle	Pen Needle, Diabetic	14	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	13	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	13	suppressed
Terazosin Hcl	Terazosin Hcl	13	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Breo Ellipta	Fluticasone/Vilanterol	12	suppressed
Budesonide	Budesonide	12	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	12	suppressed
Lansoprazole	Lansoprazole	12	suppressed
Torsemide	Torsemide	12	suppressed
Arnuity Ellipta	Fluticasone Furoate	11	suppressed
Carbamazepine Er	Carbamazepine	11	suppressed
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	11	suppressed
Fluconazole	Fluconazole	11	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	11	suppressed
Unifine Safecontrol Pen Needle	Pen Needle,dual Safety,diabetc	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error